Nuveen Asset Management, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,405,134
-43.2%
451,302
-34.7%
0.00%
-50.0%
Q2 2023$16,548,636
+168591.5%
690,966
+32.6%
0.01%
+50.0%
Q1 2023$9,810
+23.2%
521,249
+4.2%
0.00%
+33.3%
Q4 2022$7,961
-99.9%
500,077
-46.2%
0.00%
-50.0%
Q3 2022$15,198,000
-1.6%
928,973
-15.3%
0.01%0.0%
Q2 2022$15,446,000
-31.4%
1,096,202
+24.3%
0.01%
-14.3%
Q1 2022$22,532,000
+70.6%
881,888
+48.4%
0.01%
+75.0%
Q4 2021$13,211,000
+45.0%
594,281
+8.9%
0.00%
+33.3%
Q3 2021$9,113,000
-62.1%
545,696
-44.7%
0.00%
-57.1%
Q2 2021$24,061,000
-34.7%
986,502
-33.4%
0.01%
-41.7%
Q1 2021$36,869,000
-52.7%
1,480,487
+1.6%
0.01%
-53.8%
Q4 2020$77,868,000
+19.3%
1,456,557
-11.4%
0.03%
+4.0%
Q3 2020$65,272,000
+8.8%
1,643,479
+32.8%
0.02%
+4.2%
Q2 2020$59,978,000
-29.2%
1,237,433
-38.3%
0.02%
-41.5%
Q1 2020$84,743,000
-9.8%
2,005,744
-8.7%
0.04%
+13.9%
Q4 2019$93,984,000
+68.0%
2,196,918
+41.3%
0.04%
+56.5%
Q3 2019$55,950,000
+31.8%
1,554,597
-2.1%
0.02%
+35.3%
Q2 2019$42,444,000
+4081.7%
1,587,903
+5476.9%
0.02%
+240.0%
Q4 2015$1,015,000
-3.3%
28,473
-10.4%
0.01%
-16.7%
Q3 2015$1,050,000
-22.5%
31,765
-1.8%
0.01%
-14.3%
Q2 2015$1,355,000
+24.5%
32,355
-27.7%
0.01%0.0%
Q1 2014$1,088,000
-10.2%
44,723
-7.8%
0.01%
-12.5%
Q4 2013$1,212,00048,5200.01%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders